ArticleJournal of neuroengineering and rehabilitation2025
Evaluation of a control paradigm allowing heart rate guided rehabilitative exercise for boys with Duchenne muscular dystrophy.
Article in Journal of neuroengineering and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Meeting report: Translating exercise research in dystrophinopathy to the clinic.Journal of neuromuscular diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAerobic cycle-training counters deconditioning and induces muscle and cardiorespiratory benefits in various neuromuscular disorders. However, its application to Duchenne muscular dystrophy (DMD) is limited due to lack of exercise prescription guidelines, particularly for intensity. A balance between beneficial versus harmful effects of muscle activity must be established given the weakness and concerns of contraction-induced damage inherent to DMD. Previous studies in DMD used motor-assisted cycling applying subjective ratings of perceived exertion to guide exercise intensity, whereas objective parameters such as heart rate (HR) or work performed were not reported. In efforts to develop exercise guidelines for DMD, we designed a motor-assisted cycle-exercise paradigm using closed-loop control of motor effort and individualization of intensity based on HR. Feasibility of this paradigm in DMD was tested in the home setting with remote clinical supervision.
methodsA closed-loop controller was developed with user-defined saturation points for cadence and baseline motor inputs to ensure safety of cycling and adjustments in level of muscle overload (assistive current). The controller allowed remote, interactive adjustment of current based on HR biofeedback, providing cycling assistance when velocity approached a lower-bound and resistance when the upper-bound was approached. A target intensity of 40-50% HR reserve was individualized for each participant and motor effort was adjusted accordingly by the clinician. Force-sensors were embedded in the pedals for quantification of passive and active power.
resultsSix ambulatory boys with DMD (aged 7.7 ± 0.9 years) completed at least two bouts of cycling exercise (3-10 min per bout) with an average 0.53 ± 0.15 amps assistive current (range 0.3-0.8 amps). HR increased from rest during passive and active cycling (mean 109.2 ± 6.1; 119.2 ± 8.5; 149.7 ± 4.6 bpm respectively), where boys were actively exercising at 45% of HR reserve at an average cycling power of 5.7 ± 1.3 watts (ranging 3-8 watts depending on disease severity).
conclusionThese results show for the first time that boys with DMD can cycle actively to generate power and raise HR to a prescribed intensity, supporting feasibility of this home-based, remotely-supervised control paradigm. They warrant future study to establish clinical exercise prescription parameters and the potential of aerobic cycling as a rehabilitative strategy in DMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.